Macrophage Metabolism As Therapeutic Target for Cancer, Atherosclerosis, and Obesity
- PMID: 28360914
- PMCID: PMC5350105
- DOI: 10.3389/fimmu.2017.00289
Macrophage Metabolism As Therapeutic Target for Cancer, Atherosclerosis, and Obesity
Abstract
Macrophages are not only essential components of innate immunity that contribute to host defense against infections, but also tumor growth and the maintenance of tissue homeostasis. An important feature of macrophages is their plasticity and ability to adopt diverse activation states in response to their microenvironment and in line with their functional requirements. Recent immunometabolism studies have shown that alterations in the metabolic profile of macrophages shape their activation state and function. For instance, to fulfill their respective functions lipopolysaccharides-induced pro-inflammatory macrophages and interleukin-4 activated anti-inflammatory macrophages adopt a different metabolism. Thus, metabolic reprogramming of macrophages could become a therapeutic approach to treat diseases that have a high macrophage involvement, such as cancer. In the first part of this review, we will focus on the metabolic pathways altered in differentially activated macrophages and link their metabolic aspects to their pro- and anti-inflammatory phenotype. In the second part, we will discuss how macrophage metabolism is a promising target for therapeutic intervention in inflammatory diseases and cancer.
Keywords: M1–M2 macrophage polarization; cancer; immunometabolism; inflammatory diseases; metabolic reprogramming; metabolic therapy; microenvironment; tumor-associated macrophages.
Figures



Similar articles
-
Metabolic influence on macrophage polarization and pathogenesis.BMB Rep. 2019 Jun;52(6):360-372. doi: 10.5483/BMBRep.2019.52.6.140. BMB Rep. 2019. PMID: 31186085 Free PMC article. Review.
-
Metabolic Regulation of Macrophage Polarization in Cancer.Trends Cancer. 2019 Dec;5(12):822-834. doi: 10.1016/j.trecan.2019.10.007. Epub 2019 Nov 6. Trends Cancer. 2019. PMID: 31813459 Free PMC article. Review.
-
Metabolic reprogramming in macrophage responses.Biomark Res. 2021 Jan 6;9(1):1. doi: 10.1186/s40364-020-00251-y. Biomark Res. 2021. PMID: 33407885 Free PMC article. Review.
-
Metabolic reprogramming of macrophages and its involvement in inflammatory diseases.EXCLI J. 2021 Mar 11;20:628-641. doi: 10.17179/excli2020-3053. eCollection 2021. EXCLI J. 2021. PMID: 33883988 Free PMC article. Review.
-
Metabolic reprogramming of macrophages during infections and cancer.Cancer Lett. 2019 Jun 28;452:14-22. doi: 10.1016/j.canlet.2019.03.015. Epub 2019 Mar 21. Cancer Lett. 2019. PMID: 30905817 Review.
Cited by
-
Macrophages in Atherosclerosis Regression.Arterioscler Thromb Vasc Biol. 2020 Jan;40(1):20-33. doi: 10.1161/ATVBAHA.119.312802. Epub 2019 Nov 14. Arterioscler Thromb Vasc Biol. 2020. PMID: 31722535 Free PMC article. Review.
-
Glutamine Metabolism in Macrophages: A Novel Target for Obesity/Type 2 Diabetes.Adv Nutr. 2019 Mar 1;10(2):321-330. doi: 10.1093/advances/nmy084. Adv Nutr. 2019. PMID: 30753258 Free PMC article. Review.
-
Identification of macrophage-related genes correlated with prognosis and immunotherapy efficacy in non-small cell lung cancer.Heliyon. 2024 Mar 7;10(6):e27170. doi: 10.1016/j.heliyon.2024.e27170. eCollection 2024 Mar 30. Heliyon. 2024. PMID: 38500993 Free PMC article.
-
Altered mTORC1 signalling may contribute to macrophage dysregulation in hidradenitis suppurativa.Inflamm Res. 2018 Mar;67(3):207-208. doi: 10.1007/s00011-017-1115-6. Epub 2017 Nov 11. Inflamm Res. 2018. PMID: 29127444 No abstract available.
-
Reprogramming tumor-associated macrophages as a unique approach to target tumor immunotherapy.Front Immunol. 2023 Apr 17;14:1166487. doi: 10.3389/fimmu.2023.1166487. eCollection 2023. Front Immunol. 2023. PMID: 37138860 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials